Global Hospital Injectable Drugs Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Executive Summary
According to GRD Survey data, the global Hospital Injectable Drugs market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Hospital Injectable Drugs market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Hospital Injectable Drugs in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Market Snapshot, By Application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
Sanofi
Sandoz (Novartis)
Otsuka
Nichi-Iko Group (Sagent)
JW Life Science
Hospira (Pfizer Inc.)
Hikma Pharmaceuticals PLC
Grifols
Gland Pharma
Fresenius Kabi
Endo International PLC
Dr. Reddy's Laboratories Ltd
CR Double-Crane
Cisen Pharmaceutical
Baxter
B.Braun
Auromedics
The study objectives of this report are:
To study and analyze the global Hospital Injectable Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Hospital Injectable Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Hospital Injectable Drugs manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hospital Injectable Drugs market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Hospital Injectable Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Hospital Injectable Drugs are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Hospital Injectable Drugs Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Hospital Injectable Drugs Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Hospital Injectable Drugs
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Hospital Injectable Drugs Sales Channel and Distributors Analysis
3.3.1 Hospital Injectable Drugs Sales Channel
3.3.2 Hospital Injectable Drugs Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Hospital Injectable Drugs Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Hospital Injectable Drugs Type Introduction
4.1.1 Generic Sterile Injectables
4.1.2 Sterile Intravenous (IV) Solutions
4.2 Global Hospital Injectable Drugs Sales by Type 2016-2021
4.3 Global Hospital Injectable Drugs Revenue by Type 2016-2021
4.4 Global Hospital Injectable Drugs Price by Type 2016-2021
5 Market Segment: by Application
5.1 Hospital Injectable Drugs Type Introduction
5.1.1 Oncology
5.1.2 Anesthesia
5.1.3 Anti-Infectives
5.1.3 Parenteral Nutrition
5.1.4 Cardiovascular Diseases
5.2 Global Hospital Injectable Drugs Sales by Application 2016-2021
5.3 Global Hospital Injectable Drugs Revenue by Application 2016-2021
5.4 Global Hospital Injectable Drugs Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Hospital Injectable Drugs Market by Region
6.1.1 Global Hospital Injectable Drugs Sales by Regions
6.1.2 Global Hospital Injectable Drugs Revenue by Regions
6.2 North America Hospital Injectable Drugs Market 2016-2021
6.3 Europe Hospital Injectable Drugs Market 2016-2021
6.4 Asia Pacific Hospital Injectable Drugs Market 2016-2021
6.5 South America Hospital Injectable Drugs Market 2016-2021
6.6 Middle East and Africa Hospital Injectable Drugs Market 2016-2021
7 North America
7.1 North America Hospital Injectable Drugs Market by Country 2016-2021
7.1.1 North America Hospital Injectable Drugs Sales by Country
7.1.2 North America Hospital Injectable Drugs Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Hospital Injectable Drugs Market by Country 2016-2021
8.1.1 Europe Hospital Injectable Drugs Sales by Country
8.1.2 Europe Hospital Injectable Drugs Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Hospital Injectable Drugs Market by Country 2016-2021
9.1.1 Asia Pacific Hospital Injectable Drugs Sales by Country
9.1.2 Asia Pacific Hospital Injectable Drugs Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Hospital Injectable Drugs Market by Country 2016-2021
10.1.1 South America Hospital Injectable Drugs Sales by Country
10.1.2 South America Hospital Injectable Drugs Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Hospital Injectable Drugs Market by Country 2016-2021
11.1.1 Middle East and Africa Hospital Injectable Drugs Sales by Country
11.1.2 Middle East and Africa Hospital Injectable Drugs Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Teva Pharmaceutical
12.1.1 Teva Pharmaceutical Company Information
12.1.2 Teva Pharmaceutical Hospital Injectable Drugs Product Portfolio, Specification and Application
12.1.3 Teva Pharmaceutical Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Teva Pharmaceutical Key Development
12.2 Sichuan Kelun Pharmaceutical
12.2.1 Sichuan Kelun Pharmaceutical Company Information
12.2.2 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Portfolio, Specification and Application
12.2.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sichuan Kelun Pharmaceutical Key Development
12.3 Shijiazhuang No. 4 Pharmaceutical
12.3.1 Shijiazhuang No. 4 Pharmaceutical Company Information
12.3.2 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Portfolio, Specification and Application
12.3.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Shijiazhuang No. 4 Pharmaceutical Key Development
12.4 Shandong Hualu Pharmaceutical
12.4.1 Shandong Hualu Pharmaceutical Company Information
12.4.2 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Portfolio, Specification and Application
12.4.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Shandong Hualu Pharmaceutical Key Development
12.5 Sanofi
12.5.1 Sanofi Company Information
12.5.2 Sanofi Hospital Injectable Drugs Product Portfolio, Specification and Application
12.5.3 Sanofi Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Sanofi Key Development
12.6 Sandoz (Novartis)
12.6.1 Sandoz (Novartis) Company Information
12.6.2 Sandoz (Novartis) Hospital Injectable Drugs Product Portfolio, Specification and Application
12.6.3 Sandoz (Novartis) Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Sandoz (Novartis) Key Development
12.7 Otsuka
12.7.1 Otsuka Company Information
12.7.2 Otsuka Hospital Injectable Drugs Product Portfolio, Specification and Application
12.7.3 Otsuka Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Sandoz (Novartis) Key Development
12.9 JW Life Science
12.9.1 JW Life Science Company Information
12.9.2 JW Life Science Hospital Injectable Drugs Product Portfolio, Specification and Application
12.9.3 JW Life Science Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 JW Life Science Key Development
12.8 Nichi-Iko Group (Sagent)
12.8.1 Nichi-Iko Group (Sagent) Company Information
12.8.2 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Portfolio, Specification and Application
12.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Nichi-Iko Group (Sagent) Key Development
12.11 Hikma Pharmaceuticals PLC
12.11.1 Hikma Pharmaceuticals PLC Company Information
12.11.2 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Portfolio, Specification and Application
12.11.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Hikma Pharmaceuticals PLC Key Development
12.12 Grifols
12.12.1 Grifols Company Information
12.12.2 Grifols Hospital Injectable Drugs Product Portfolio, Specification and Application
12.12.3 Grifols Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Grifols Key Development
12.13 Gland Pharma
12.13.1 Gland Pharma Company Information
12.13.2 Gland Pharma Hospital Injectable Drugs Product Portfolio, Specification and Application
12.13.3 Gland Pharma Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Gland Pharma Key Development
12.14 Fresenius Kabi
12.14.1 Fresenius Kabi Company Information
12.14.2 Fresenius Kabi Hospital Injectable Drugs Product Portfolio, Specification and Application
12.14.3 Fresenius Kabi Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Fresenius Kabi Key Development
12.15 Endo International PLC
12.15.1 Endo International PLC Company Information
12.15.2 Endo International PLC Hospital Injectable Drugs Product Portfolio, Specification and Application
12.15.3 Endo International PLC Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Endo International PLC Key Development
12.17 CR Double-Crane
12.18 Cisen Pharmaceutical
12.19 Baxter
12.20 B.Braun
12.21 Auromedics
13 Global Hospital Injectable Drugs Market Forecast by Region by Type and by Application
13.1 Global Hospital Injectable Drugs Sales, Revenue Forecast 2022-2027
13.2 Global Hospital Injectable Drugs Forecast by Regions
13.2.1 Global Hospital Injectable Drugs Sales Forecast by Region 2022-2027
13.2.2 Global Hospital Injectable Drugs Revenue Forecast by Region 2022-2027
13.3 Global Hospital Injectable Drugs Forecast by Type
13.3.1 Global Hospital Injectable Drugs Sales Forecast by Type 2022-2027
13.3.2 Global Hospital Injectable Drugs Revenue Forecast by Type 2022-2027
13.3.3 Global Hospital Injectable Drugs Price Forecast by Type 2022-2027
13.4 Global Hospital Injectable Drugs Forecast by Application
13.4.1 Global Hospital Injectable Drugs Sales Forecast by Application 2022-2027
13.4.2 Global Hospital Injectable Drugs Revenue Forecast by Application 2022-2027
13.4.3 Global Hospital Injectable Drugs Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Hospital Injectable Drugs Production Specifications
Table 2: Drivers in Hospital Injectable Drugs Market
Table 3: Restraints Hospital Injectable Drugs Market
Table 4: Opportunity in Hospital Injectable Drugs Market
Table 5: Comparion of Alternative and Hospital Injectable Drugs
Table 6: Hospital Injectable Drugs Raw Materials Key Suppliers List
Table 7: Hospital Injectable Drugs Distributors List
Table 8: Hospital Injectable Drugs Major Buyers in Application One
Table 9: Hospital Injectable Drugs Major Buyers in Application Two
Table 10: Hospital Injectable Drugs Major Buyers in Application Three
Table 11: Global Hospital Injectable Drugs Sales (K Units) by Type 2016-2021
Table 12: Global Hospital Injectable Drugs Sales Market Share by Type 2016-2021
Table 13: Global Hospital Injectable Drugs Revenue (Million USD) by Type 2016-2021
Table 14: Global Hospital Injectable Drugs Revenue Market Share by Type 2016-2021
Table 15: Global Hospital Injectable Drugs Price by Type 2016-2021
Table 16: Global Hospital Injectable Drugs Sales (K Units) by Application 2016-2021
Table 17: Global Hospital Injectable Drugs Sales Market Share by Application 2016-2021
Table 18: Global Hospital Injectable Drugs Revenue (Million USD) by Application 2016-2021
Table 19: Global Hospital Injectable Drugs Revenue Market Share by Application 2016-2021
Table 20: Global Hospital Injectable Drugs Price by Application 2016-2021
Table 21: Global Hospital Injectable Drugs Sales (K Units) by Region 2016-2021
Table 22: Global Hospital Injectable Drugs Sales Market Share by Region 2016-2021
Table 23: Global Hospital Injectable Drugs Revenue (Million USD) by Region 2016-2021
Table 24: Global Hospital Injectable Drugs Revenue Market Share by Region 2016-2021
Table 25: North America Hospital Injectable Drugs Sales (K Units) by Country 2016-2021
Table 26: North America Hospital Injectable Drugs Sales Market Share by Country 2016-2021
Table 27: North America Hospital Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 28: North America Hospital Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 29: Europe Hospital Injectable Drugs Sales (K Units) by Country 2016-2021
Table 30: Europe Hospital Injectable Drugs Sales Market Share by Country 2016-2021
Table 31: Europe Hospital Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 32: Europe Hospital Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Hospital Injectable Drugs Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Hospital Injectable Drugs Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Hospital Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Hospital Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 37: South America Hospital Injectable Drugs Sales (K Units) by Country 2016-2021
Table 38: South America Hospital Injectable Drugs Sales Market Share by Country 2016-2021
Table 39: South America Hospital Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 40: South America Hospital Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Hospital Injectable Drugs Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Hospital Injectable Drugs Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Hospital Injectable Drugs Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Hospital Injectable Drugs Revenue Market Share by Country 2016-2021)
Table 45 Teva Pharmaceutical Company Information
Table 46 Teva Pharmaceutical Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 47 Teva Pharmaceutical Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Sichuan Kelun Pharmaceutical Company Information
Table 49 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 50 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Shijiazhuang No. 4 Pharmaceutical Company Information
Table 52 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 53 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Shandong Hualu Pharmaceutical Company Information
Table 55 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 56 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Sanofi Company Information
Table 58 Sanofi Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 59 Sanofi Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Sandoz (Novartis) Company Information
Table 61 Sandoz (Novartis) Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 62 Sandoz (Novartis) Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Otsuka Company Information
Table 64 Otsuka Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 65 Otsuka Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Nichi-Iko Group (Sagent) Company Information
Table 67 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 68 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 JW Life Science Company Information
Table 70 JW Life Science Hospital Injectable Drugs Product Portfolio, Specification and Application
Table 71 JW Life Science Hospital Injectable Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Hospital Injectable Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Hospital Injectable Drugs Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Hospital Injectable Drugs Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Hospital Injectable Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Hospital Injectable Drugs Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Hospital Injectable Drugs Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Hospital Injectable Drugs Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Hospital Injectable Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Hospital Injectable Drugs Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Hospital Injectable Drugs Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Hospital Injectable Drugs Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Hospital Injectable Drugs Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: Hospital Injectable Drugs Picture
Figure 2: Global Hospital Injectable Drugs Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Hospital Injectable Drugs Supply Chain Analysis
Figure 5: Hospital Injectable Drugs Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Generic Sterile Injectables
Figure 7: Product Picture of Sterile Intravenous (IV) Solutions
Figure 8: Global Hospital Injectable Drugs Sales Market Share by Type, 2020
Figure 9: Global Hospital Injectable Drugs Revenue Market Share by Type, 2020
Figure 10: Hospital Injectable Drugs in Oncology
Figure 11: Global Hospital Injectable Drugs Market: Oncology 2016-2021
Figure 12: Hospital Injectable Drugs in Anesthesia
Figure 13: Global Hospital Injectable Drugs Market: Anesthesia 2016-2021
Figure 14: Global Hospital Injectable Drugs Sales Market Share by Application, 2020
Figure 15: Global Hospital Injectable Drugs Revenue Market Share by Application, 2020
Figure 16: Global Hospital Injectable Drugs Sales Market Share by Region 2016-2021
Figure 17: Global Hospital Injectable Drugs Revenue Market Share by Region 2016-2021
Figure 18: North America Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 19: North America Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 20: Europe Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 21: Europe Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 24: South America Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 25: South America Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 28: North America Hospital Injectable Drugs Sales Market Share by Country, 2020
Figure 29: North America Hospital Injectable Drugs Revenue Market Share by Country, 2020
Figure 30: United States Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 31: United States Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 32: Canada Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 33: Canada Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 35: Mexico Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 36: Europe Hospital Injectable Drugs Sales Market Share by Country, 2020
Figure 37: Europe Hospital Injectable Drugs Revenue Market Share by Country, 2020
Figure 38: Germany Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 39: Germany Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 40: France Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 41: France Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 42: UK Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 43: UK Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 44: Italy Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 45: Italy Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 46: Russia Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 46: Russia Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 47: Spain Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 48: Spain Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Hospital Injectable Drugs Sales Market Share by Country, 2020
Figure 50: Asia Pacific Hospital Injectable Drugs Revenue Market Share by Country, 2020
Figure 51: China Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 52: China Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 53: Japan Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 54: Japan Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 55: Korea Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 56: Korea Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 59: India Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 60: India Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 61: Australia Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 62: Australia Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 63: South America Hospital Injectable Drugs Sales Market Share by Country, 2020
Figure 64: South America Hospital Injectable Drugs Revenue Market Share by Country, 2020
Figure 65: Brazil Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 66: Brazil Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 68: Argentina Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 70: Colombia Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Hospital Injectable Drugs Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Hospital Injectable Drugs Revenue Market Share by Country, 2020
Figure 73: Turkey Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 74: Turkey Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Hospital Injectable Drugs Sales (K Units) Status 2016-2021
Figure 78: South Africa Hospital Injectable Drugs Revenue (Million USD) Status 2016-2021
Figure 79: Teva Pharmaceutical Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 80: Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 81: Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 82: Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 83: Sanofi Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 84: Sandoz (Novartis) Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 85: Otsuka Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 86: Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 87: JW Life Science Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 88: Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue Market Share Globally (2019-2021)
Figure 89: Global Hospital Injectable Drugs Sales (K Units) Forecast (2022-2027)
Figure 90: Global Hospital Injectable Drugs Sales (K Units) Forecast (2022-2027)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets